Literature DB >> 7970216

Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type.

X Y Dai1, S Nanko, M Hattori, R Fukuda, K Nagata, K Isse, A Ueki, H Kazamatsuri.   

Abstract

Apolipoprotein E genotypes in 88 unrelated Japanese patients with NINCDS-ADRDA sporadic Alzheimer's disease (AD) were examined and compared with those of 93 healthy controls. Frequency of epsilon 4 allele was increased in patients with AD (31%) compared with controls (10%), as was reported previously. Individuals homozygous or heterozygous for the allele epsilon 4 had a 5.9-fold increased risk of AD. This tendency was more pronounced in early onset sporadic (= non-familial) type than late onset type. The relative risk was also greater for early onset type (RR = 11.7; 95% CI, 4.9-28.3) than late onset type (RR = 4.3; 95% CI, 2.1-8.8). Moreover, patients with homozygote for the allele epsilon 4 had a 14.7-fold increased risk of early onset sporadic AD (P < 0.005, chi 2 = 9.0, df = 1, 95% CI, 2.5-85.1). Our findings indicated that association of apolipoprotein epsilon 4 with sporadic Alzheimer's disease is more pronounced in early onset type than in late onset type.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970216     DOI: 10.1016/0304-3940(94)91081-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.

Authors:  H Bickeböller; D Campion; A Brice; P Amouyel; D Hannequin; O Didierjean; C Penet; C Martin; J Pérez-Tur; A Michon; B Dubois; F Ledoze; C Thomas-Anterion; F Pasquier; M Puel; J F Demonet; O Moreaud; M C Babron; D Meulien; D Guez; M C Chartier-Harlin; T Frebourg; Y Agid; M Martinez; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

2.  Apolipoprotein E type 4 allele and Alzheimer's disease: effect on age at onset and relative risk in different age groups.

Authors:  A Kurz; K Altland; N Lautenschlager; R Zimmer; R Busch; I Gerundt; H Lauter; U Müller
Journal:  J Neurol       Date:  1996-06       Impact factor: 4.849

3.  Diagnosis Test Meta-Analysis for Apolipoprotein E in Alzheimer's Disease.

Authors:  Xuan Xiong; Hongtao Xiao; Yuan Zhang; Dongke Yu; Junlan Chuan; Lei Zhong; Qinan Yin; Rongsheng Tong
Journal:  Dis Markers       Date:  2020-10-09       Impact factor: 3.434

Review 4.  Genetic dissection of Alzheimer disease, a heterogeneous disorder.

Authors:  G D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

5.  Immunohistochemical study of apolipoprotein E in human cerebrovascular white matter lesions.

Authors:  H Tomimoto; I Akiguchi; T Suenaga; H Wakita; S Nakamura; J Kimura; H Budka
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies.

Authors:  Seiju Kobayashi; Masaru Tateno; Tae Woo Park; Kumiko Utsumi; Hitoshi Sohma; Yoichi M Ito; Yasuo Kokai; Toshikazu Saito
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.